ImmiFlex

ImmiFlex® - Activates the immune system! ImmiFlex® contains Wellmune WGP® which is protected by more than 40 patents, and in which development, research and clinical trials more than 1.5 billion NOK (162 million euros) have been invested.

ImmiFlex® with Wellmune WGP® beta-glucans activates the immune system! ImmiFlex® is the strongest beta-glucan product on the market, with over 80% of Wellmune WGP® beta-glucans.

ImmiFlex® contains Wellmune WGP® which is protected by more than 40 patents, and in which development, research and clinical trials, done to determine if the product works and how it works, more than 1.5 billion NOK (162 million euros) have been invested. You can read more about ImmiFlex here: www.immiflex.com

How does ImmiFlex® work:

ImmiFlex® contains Wellmune WGP® beta-glucans (Beta 1,3 / 1,6 Gluco Polysaccharide) and Vitamin D, both of which are known to be good for the immune system. ImmiFlex® thus represents an entirely new way to strengthen the immune system, but its origins are actually thousands of years old. The human body has since the dawn of time developed its own ability to combat attacks from yeast, and it is this mechanism that the ingredients in ImmiFlex® activate. Namely, beta-glucans in ImmiFlex lead the important immune system cells called "neutrophils" to believe that all hostile intruders in the body are yeast. In that way, all the invaders are attacked and subsequently rendered innocuous by neutrophils.

Health Insurance

ImmiFlex® is used daily by many people as part of a "health insurance" and is particularly effective for people during periods when risk of infection is high or during times of increased stress levels.

1 capsule a day
Full effect after 5 days
Documented effect

Scientifically evaluated with proven efficacy

ImmiFlex® contains as mentioned before Wellmune WGP® beta-glucans. Wellmune WGP® is a patented natural immune system stimulator, which has been the object of a great number of research reports. Two of these reports are published in The Journal of Applied Research and the Journal of Sports Science and Medicine, among others. In 2011, Wellmune WGP® beta-glucans were scientifically assessed by EU / EFSA and became the only beta 1,3 / 1,6 glucan approved as Novel Food.

At the moment, the EU is investing almost 57 million NOK (6 million euros) on an international project to research the health benefits of specific dietary fibers. Research institutes, universities and private companies are all part of the project. Immitec contributes by investing in science and research on the substance that activates the immune system, Wellmune WGP®, which can found in products ImmiFlex, Immimarine and Imminexin.

Read more about the EU project, which Wellmune beta-glucans are a part of, here.